References
- Whitehead M. I., King R. J. B., McQueen J., Campbell S. Endometrial histology and biochemistry in climacteric women during oestrogen and oestrogen/progestogen therapy. J. R. Soc. Med. 1979; 72: 322
- Hammond C. B., Jelovsek F. R., Lee K. L., Creasman W. T., Parker R. T. Effects of long-term estrogen replacement therapy. II. Neoplasia. Am. J. Obstet. Gynecol. 1979; 133: 537
- Whitehead M. I., Townsend P. T., Pryse-Davies J., Ryder T. A., King R. J. B. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N. Engl. J. Med. 1981; 305: 1599
- Cambrell R. D., Jr. The menopause. Benefits, and risks of estrogen-progestogen replacement therapy. Fertil. Steril. 1982; 37: 457
- Julkunen M., Koistinen R., Sjöberg J., Rutanen E. M., Wahlstrom T., Seppälä M. Secretory endometrium synthesizes placental protein 14. Endocrinology 1986; 118: 1782
- Waites G. T., Wood P. L., Walker R. A., Bell S. C. Immuno-histological localization of human endometrial secretory protein, ‘pregnancy-associated endometrial α2globulin’ (α2-PEG), during the menstrual cycle. J. Reprod. Fertil. 1988; 82: 665
- Joshi S. G., Rao R., Henriques E. E., Raiker R. S., Gordon M. Luteal phase concentrations of a progestagen-associated endometrial protein (PEP) in the serum of cycling women with adequate or inadequate endometrium. J. Clin. Endocrinol. Metab. 1986; 63: 1247
- Julkunen M., Apter D., Seppälä M., Stenman U.-H., Bohn H. Serum levels of placental protein 14 reflect ovulation in non-conceptional menstrual cycles. Fertil. Steril. 1986; 45: 47
- Seppälä M., Alfthan H., Vartiainen E., Stenman U.-H. The post-menopausal uterus: the effect of hormone replacement therapy on the serum levels of secretory endometrial protein PP14/b˜-lactoglobulin homologue. Human Reprod. 1987; 2: 741
- Salacinski P. R. P., McLean C., Sykes J. E. C., Clement-Jones V. V., Lowry P. J. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3α,6α-dipenyl glycoluril (Iodogen). Anal. Biochem. 1981; 117: 136
- Greenwood F. C., Hunter W. M., Glover J. S. The preparation of 131I-labelled human growth hormone of high specific radioactivity. Biochem. J. 1963; 89: 114
- Christiansen C., Christiansen M. S., McNair P., Hagen C., Stocklund K. E., Transbøl I. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur. J. Clin. Invest. 1980; 10: 273
- Riis B. J., Thomsen K., Strom V., Christiansen C. The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am. J. Obstet. Gynecol. 1987; 156: 61
- Riis B. J., Johansen J., Christiansen C. Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women. Maturitas 1988; 10: 51
- Bohn H., Kraus W., Winckler W. New soluble placental tissue proteins: their isolation, characterization, localization and quantification. Placenta, (suppl.) 1982; 4: 67
- Bell S. C., Bohn H. Immunochemical and biochemical relationship between human pregnancy-associated secreted endometrial α1-and α2-globulins (α1 - and α2-PEG) and the soluble placental proteins 12 and 14 (PP12 and PP14). Placenta 1986; 7: 283
- Julkunen M., Raiker R. S., Joshi S. G., Bohn H., Seppälä M. Placental protein 14 and progestagen-dependent endometrial protein are immunologically indistinguishable. Human Reprod. 1986; 1: 7
- Sutcliffe R. G., Joshi S. G., Paterson W. F., Bank J. F. Serological identity between alpha uterine protein and human progestagen-dependent endometrial protein. J. Reprod. Fertil. 1982; 65: 207
- Julkunen M., Rutanen E. M., Koskimies A., Ranta T., Bohn H., Seppälä M. Distribution of placental protein 14 in tissues and body fluids during pregnancy. Br. J. Obstet. Gynaecol. 1985; 92: 1145
- Bolton A. E., Chapman M. G., Stoker R. J., Andrew C. E., Wass D., Bohn H. The radioimmunoassay of human placental protein 14 (PP14). Clin. Chim. Acta 1983; 135: 283
- Julkunen M., Wahlstrem T., Seppälä M., Koistinen R., Koskimies A., Stenman U.-H., Bohn H. Detection and localization of placental protein 14-like protein in human seminal plasma and in the male genital tract. Arch. Androl. 1984; 12(suppl.)59
- Byrjalsen I., Riis B. J., Christiansen C. Serum placenta protein 14 in pre- and post-menopausal women – dependency on oestrogen/ progestogen status. Maturitas. 1989, (Submitted)
- Magos A. L., Brincat M., Studd J. W. W., Wardle P., Schlesinger P., O'Dowd T. Amenorrhea and endometrial atrophy with continuous oral estrogen and progestogen therapy in postmenopausal women. Obstet. Gynecol. 1985; 65: 496